Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.3K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

7
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
7
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

23
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
23
Diabetic Retinopathy01:27

Diabetic Retinopathy

45
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
45
Diabetic Nephropathy01:28

Diabetic Nephropathy

24
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
24
Diabetic Neuropathy01:22

Diabetic Neuropathy

35
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria.

Kidney & blood pressure research·2018
Same author

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017
Same author

Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.

Clinical kidney journal·2016
Same author

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016
Same author

Bariatric surgery and the kidney-much benefit, but also potential harm.

Clinical kidney journal·2016
Same author

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Journal of hypertension·2016
Same journal

U- Shaped Association of Serum Parathyroid Hormone and Cognitive Dysfunction in Maintenance Haemodialysis Patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
Same journal

Biomonitoring of cyclosporine in renal transplant patients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
Same journal

Clinical and Pathological Faces of IgM Deposition in Children with Idiopathic Nephrotic Syndrome: A Single Center Experience.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
Same journal

Peritoneal Dialysis Therapy Discontinuation Due to Noninfectious Complications: Insights from a Retrospective Study in End Stage Renal Disease Patients from Saudi Arabia.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
Same journal

Urine Aquaporin-5 a biomarker in diabetic nephropathy.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
Same journal

A study of Psychiatric Morbidity and Quality of Life in Patients with Chronic Kidney Disease.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.6K

Diabetic nephropathy.

Eberhard Ritz

    Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
    |December 26, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD) in Western countries, driven by type 2 diabetes. Early detection via microalbuminuria and managing risk factors like hypertension are key to slowing progression.

    More Related Videos

    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
    08:15

    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

    Published on: May 10, 2024

    1.1K
    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
    10:31

    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

    Published on: May 2, 2025

    790

    Related Experiment Videos

    Last Updated: Apr 23, 2026

    Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
    05:06

    Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

    Published on: July 14, 2023

    2.6K
    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
    08:15

    Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

    Published on: May 10, 2024

    1.1K
    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
    10:31

    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

    Published on: May 2, 2025

    790

    Area of Science:

    • Nephrology
    • Endocrinology
    • Diabetology

    Background:

    • Diabetic nephropathy (DN) is the primary cause of end-stage renal disease (ESRD) in Western nations, largely due to the increasing prevalence of type 2 diabetes.
    • Classical DN progresses through stages, with microalbuminuria (MA) signaling overt disease onset after glomerular hyperfiltration.

    Discussion:

    • Key risk factors for DN include family history, maternal hyperglycemia, hypertension, obesity, and insulin resistance. Poor glycemic control (HbA1c) and elevated systolic blood pressure exacerbate risk.
    • Proteinuria and smoking significantly promote DN progression. Lowering blood pressure and renin-angiotensin system (RAS) blockade can reduce microalbuminuria onset.
    • Established DN requires strict systolic blood pressure control (<130 mm Hg) and obligatory RAS blockade. Cardiovascular risk factor management is critical.

    Key Insights:

    • Antihypertensive management in DN is complicated by volume sensitivity, RAS activation, and autonomic neuropathy.
    • Diabetic patients with DN face high cardiac event rates, difficult glycemic control, and complications like gastroparesis and diabetic foot.
    • Renal replacement therapy, including hemodialysis, peritoneal dialysis, or transplantation, should be considered relatively early.

    Outlook:

    • Renal transplantation, including combined kidney/pancreas or pancreas-after-kidney options, represents the optimal treatment for eligible DN patients.
    • Continued research into managing complex comorbidities and optimizing renal replacement strategies is essential.
    • Preventive strategies targeting modifiable risk factors are crucial for reducing the burden of DN.